September 23, 2010 - Results from a study evaluating the safety and clinical efficacy of the Promus Element everolimus-eluting coronary stent will be released at the Transcatheter Cardiovascular Therapeutics (TCT) meeting in Washington, D.C.

September 23, 2010 – The first consensus document for treating structural heart disease has been published by the Society for Cardiovascular Angiography and Interventions (SCAI).

September 22, 2010 - A new intravascular imaging system will be highlighted at the annual Transcatheter Cardiovascular Therapeutics (TCT) meeting in Washington, D.C. The C7-XR optical coherence tomography (OCT) platform, made by St. Jude Medical, offers physicians a new tool for intravascular lesion assessment.

The 23rd annual International Symposium on Endovascular Therapy (ISET) will take place from Jan. 16-20, 2011 in Miami Beach. At the meeting, more than 1,500 members of the endovascular community-including physicians, researchers, nurses and professionals from around the world-will discuss the field’s controversies and advances.

September 21, 2010 - Patent infringement claims by St. Jude Medical Systems against the Volcano Corporation are without merit, the company said Tuesday.

September 21, 2010 – The first patients have been enrolled in a trial testing a new treatment for refractory angina. The COSIRA (Coronary Sinus Reducer for Treatment of Refractory Angina) trial is designed to assess the clinical efficacy of the Neovasc Reducer. The goal is to minimize angina symptoms after six months.

September 20, 2010 - Results for the first-in-human study for a robotic cath lab navigation system will be announced at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 conference. Corindus Vascular Robotics will present information on the study involving its CorPath 200 System.

September 20, 2010 — McLeod Regional Medical Center in Florence, S.C., has signed a new agreement to help streamline its cardiology workflow.